Cartesian Therapeutics, Inc. (RNAC)
6.83
+0.97
(+16.55%)
USD |
NASDAQ |
Jun 09, 16:00
6.70
-0.13
(-1.90%)
After-Hours: 17:44
Cartesian Therapeutics EPS Diluted (Quarterly) : -1.459 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| C4 Therapeutics, Inc. | -0.1993 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.18M |
| Revenue (Quarterly) | 0.078M |
| Total Expenses (Quarterly) | 39.26M |
| Enterprise Value | 60.49M |
| Gross Profit Margin (Quarterly) | -688.5% |
| Profit Margin (Quarterly) | -50.23K% |
| Earnings Yield | -84.89% |
| Normalized Earnings Yield | -55.97 |